FREE SHIPPING on Every Order – Because We’re Serious About Your Heart Health!
Powered by ancient herbal medicine, proven by clinical science, built for those ready to fight back.
“We need to stop talking about expensive drugs, and we need to get down to the root causes.”
That’s exactly what HeartBlast FX is built on — a natural, clinically inspired system targeting the root of heart dysfunction, not just masking the symptoms.
Real recovery starts here.
The first U.S. formulation to combine Terminalia Arjuna, Hawthorn, and Astragalus in a single EF-targeting system.
Designed to optimize cardiac output, restore rhythm, and help raise EF levels from 35% to 50%+ based on human trials.
How it works:
How it works:
How it works:
Anyone with EF under 50%, or struggling with low energy and cardiac fatigue
Adults managing heart failure, post-MI recovery, or chronic stress-related arrhythmias
People looking for serious, targeted heart support beyond fish oil and fluff
HeartBlast FX™ comes as a smart, split-dose protocol across three capsules:
Terminalia Arjuna Extract: 500 mg, 2x/day
Hawthorn Berry Extract: 300 mg, 2x/day
Astragalus Extract: 400 mg, 2x/day
Formulated for maximum efficacy, not convenience.
Terminalia Arjuna is almost nonexistent in Western supplements, despite powerful evidence.
No other formula offers this synergistic trio at full clinical strength.
Most "heart supplements" are either underdosed or loaded with ineffective fillers. This isn't that.
6.7+ million Americans live with heart failure
Over 3.3 million have clinically reduced EF (under 40%)
Hospitalizations cost the U.S. $30B+ annually
25% of patients are readmitted within 30 days
Projected to hit 8.5+ million people by 2030
Arjuna - improves EF and ventricular function
Hawthorn - stabilizes rhythm and improves contraction strength
Astragalus - powers energy and vascular repair
Together, they form the most comprehensive natural heart stack ever made
Full 30-day supply of all three powerful, clinically-backed ingredients
Formulated to support heart strength, blood flow, and cardiac function
Made in FDA-registered, GMP-certified facilities right here in the U.S.A.
100% natural – no shortcuts, no fillers, no fluff
Backed by ancient botanical wisdom and modern clinical science
Designed specifically for those who refuse to give up on their heart
Trusted by people rebuilding heart health from the inside out
Most ingredients are well-tolerated, but always consult your cardiologist before starting.
Many report better energy and stamina in 2-4 weeks. EF improvements take consistent use over 3-6 months.
Usually mild or none. Some may experience digestive adjustment. Take with meals.
HeartBlast FX™ isn't just a supplement. It's a movement.
A movement to fight heart failure with real tools — not prescriptions that mask symptoms.
Built on ancient botanical wisdom. Proven by clinical research.
Formulated for the fighters — the ones who refuse to give up on their heart.
This protocol wasn’t created for the masses. It was created for the relentless, the hopeful, and the unbreakable.
Because the truth is: your heart can recover. And this is how you help it fight back — naturally, powerfully, and without compromise.
No gimmicks. No guesswork. Just results.
Welcome to the recovery revolution. Welcome to HeartBlast FX™.
Here are the 4 updated studies on Terminalia arjuna and Ejection Fraction (EF), including direct links to each source:
Srivastava S et al. (2022)
• Effect of E‑OJ‑01 (Oxyjun™) on Left Ventricular Ejection Fraction and Myocardial Oxygen Consumption: A Randomized, Double‑Blind, Placebo‑Controlled Study.
Published in Nutritional Journal. Demonstrated a +6.3% improvement in LVEF over 8 weeks vs. placebo.
🔗 https://pubmed.ncbi.nlm.nih.gov/36349244
• Maulik SK et al. (2016)
Clinical efficacy of water extract of stem bark of Terminalia arjuna in chronic heart failure patients.
Published in Phytomedicine. Found no significant change in LVEF over 12 weeks.
🔗 https://www.sciencedirect.com/science/article/abs/pii/S0944711316000489
🔗 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637339
• Kuchewar V et al. (2024)
A Randomized Controlled Clinical Study to Evaluate the Effect of Terminalia Arjuna Add-On Medication on Cardiac Function in Coronary Artery Disease.
Found improvements in EF, 6-minute walk test, and lipid profile.
🔗 https://www.researchgate.net/publication/385775920
🔗 https://www.nutritionaloutlook.com/view/arjuna-bark-extract-oxyjun-supports-left-ventricle-ejection-fraction-says-recent-study
• Bharani A et al. (1995)
Efficacy of Terminalia arjuna in chronic heart failure: a double-blind, placebo-controlled study.
Published in Journal of the Association of Physicians of India. Found improvements in clinical symptoms and likely EF in severe CHF.
🔗 https://www.sciencedirect.com/science/article/pii/016752739502320V
Here are four key studies on Hawthorn extract (Crataegus) focusing on left ventricular ejection fraction (LVEF) and cardiac function, complete with links and summaries:
• HERB‑CHF Trial (2009)
A randomized, double-blind, placebo-controlled study in 120 NYHA class II–III heart failure patients (LVEF ≤40%) over 6 months. The hawthorn group (450 mg twice daily) showed a modest but statistically significant increase in LVEF (P=0.04), though no improvement in exercise capacity or symptoms ScienceDirect+15PubMed+15ClinicalTrials.gov+15.
🔗 Herb-CHF Full Text PDF
• SPICE Trial – WS 1442 Extract (2008)
A large-scale trial (n=2681, NYHA II–III, LVEF ≤35%) using 900 mg/day of WS 1442 over 24 months. There was no significant difference in primary outcomes, but a subgroup with LVEF ≥25% experienced a 39.7% reduction in sudden cardiac death Deep Blue RepositoriesMDPI+9PubMed+9SpringerLink+9.
🔗 SPICE Trial Summary
• HFpEF Exploratory Study – WS 1442 (2014)
In 140 HFpEF patients (NYHA II), eight weeks of aerobic training plus WS 1442 showed tendencies toward improved LVEF, better 2 km walking time (–12.7% vs –8.4%, P=0.019), and enhanced cardiac oxygen utilization Nature+5PubMed+5PubMed+5CEEM Journal+14MDPI+14SpringerLink+14.
🔗 Trial DOI: 10.3390/sports2030059
• Cochrane and Review Findings (2005‑2018)
Systematic reviews note that hawthorn extracts (LI 132, WS 1442) significantly improve LVEF, pressure–heart rate product, and exercise tolerance in mild-to-moderate CHF patients. However, no mortality benefit is established MDPI+1ResearchGate+1Nature+3SpringerLink+3AAFP+3.
🔗 AAFP Overview (2005)
Here are four key studies on Astragalus membranaceus focusing on ejection fraction (EF) and left ventricular function, complete with summaries and direct links:
• Xu Han et al. (2024)
Effect of Astragalus membranaceus on left ventricular remodeling in HFrEF: systematic review & meta-analysis
Frontiers in Pharmacology – 19 RCTs (n=1,565) showed that Astragalus, combined with standard therapy, increased LVEF by a mean of 5.82% (95% CI: 4.61–7.03, p<0.00001), and significantly reduced left ventricular end-diastolic diameter (LVEDD) and systolic diameter (LVESD) Wikipedia+14PMC+14Frontiers+14PubMed+1Frontiers+1.
🔗 https://pubmed.ncbi.nlm.nih.gov/38283626
• Han X. et al. (2024)
Effect of astragalus injection on left ventricular remodeling in HFmrEF: systematic review & meta-analysis
Frontiers in Cardiovascular Medicine – 10 RCTs (n=995 HFmrEF patients) found a 4.56% mean increase in LVEF (95% CI: 3.68–5.44, p<0.00001), improvements in ventricular volumes, NT-proBNP, and clinical efficacy PubMedFrontiers.
🔗 https://doi.org/10.3389/fcvm.2024.1374114
• Yang WJ et al. (2011)
Clinical effect of Astragalus granule on chronic heart failure
A 30-day RCT in 90 CHF patients testing three dosage levels (2.25g, 4.5g, 7.5g twice daily) found LVEF increases to ~59–62% in medium/high-dose groups vs. ~51% in low-dose (P<0.01) Frontiers+1PubMed+1Wikipedia+5SpringerLink+5Frontiers+5.
🔗 https://doi.org/10.1007/s11655-011-0647-9
• Xu Qiyao et al. (2024)
Combination decoction of Astragalus mongholicus & Salvia miltiorrhiza improves pressure-overload HF
Preclinical rat model (pressure-overload HF) showed that the decoction significantly prevented LVEF decline and improved cardiac function, likely via inhibition of ferroptosis pathways SpringerLinkFrontiers+1Wikipedia+1.
🔗 https://doi.org/10.3389/fphar.2024.1447546
These studies demonstrate real-world and laboratory results supporting HeartBlast FX™'s formula.
Always consult your healthcare provider for personal recommendations.
These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. The information provided on this website or by this company is for educational purposes only and is not intended as a substitute for advice from your physician or other health care professional. You should not use the information on this website for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Always consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you suspect you might have a health problem.
HeartBlast FX™ is a dietary supplement and should be used only as directed on the label. Individual results may vary. The testimonials and statements on this page are not intended to guarantee that anyone will achieve the same or similar results. This site does not provide medical advice, diagnosis, or treatment.
Use of this website is subject to our Terms and Conditions and Privacy Policy.
While we don’t have a physical storefront (yet!), we’re always here for you — online, anytime.
Have a question about your order? Need help choosing the right HeartBlast FX package?
Drop us a message using the form above, and our team will get back to you within 48 hours.
Customer Support Hours:
Monday–Friday, 9AM–4PM PST
Online Orders Only
Your heart matters to us — and so does your experience.